Thanks for this, I had forgotten about the shortening of review timeframes for each reiteration.
As you said crossing to the September quarter might work either way as it would therefore include the additional cash from recent oppies and highlight a better Finsbury position to negotiate with investors, but the revenue component would be diminished (but then again US investors understand this) the more R&D a company does the faster it gets to the end goal of commercialisation.
So failing further market meltdown this cross over to include September quarterlies might be a good thing, but they don't usually get released until around the 20th or so.
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-8571
-
- There are more pages in this discussion • 11,871 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EL8
ELEVATE URANIUM LTD
Murray Hill, MD & CEO
Murray Hill
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online